Smith & Nephew plc (LON:SN) declared a dividend on Thursday, July 27th, Upcoming.Co.Uk reports. Investors of record on Thursday, October 5th will be given a dividend of $0.12 per share on Wednesday, November 1st. This represents a dividend yield of 0.72%. The ex-dividend date of this dividend is Thursday, October 5th. The official announcement can be seen at this link.

Shares of Smith & Nephew plc (SN) opened at 1385.00 on Wednesday. Smith & Nephew plc has a 1-year low of GBX 1,064.91 and a 1-year high of GBX 1,412.00. The firm has a 50-day moving average of GBX 1,365.42 and a 200 day moving average of GBX 1,321.84. The stock’s market cap is GBX 12.13 billion.

In related news, insider Virginia Bottomley bought 223 shares of the company’s stock in a transaction that occurred on Wednesday, August 16th. The shares were bought at an average price of GBX 1,380 ($18.30) per share, for a total transaction of £3,077.40 ($4,081.97).

SN has been the topic of several recent analyst reports. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and set a GBX 1,380 ($18.30) price objective on shares of Smith & Nephew plc in a research report on Monday, September 11th. J P Morgan Chase & Co lifted their target price on shares of Smith & Nephew plc from GBX 1,280 ($16.98) to GBX 1,361 ($18.05) and gave the stock a “neutral” rating in a report on Monday, July 31st. Credit Suisse Group reaffirmed a “neutral” rating and issued a GBX 1,280 ($16.98) target price on shares of Smith & Nephew plc in a report on Friday, July 28th. Deutsche Bank AG reiterated a “hold” rating and issued a GBX 1,200 ($15.92) target price on shares of Smith & Nephew plc in a research note on Friday, July 28th. Finally, Jefferies Group LLC increased their price target on shares of Smith & Nephew plc from GBX 1,350 ($17.91) to GBX 1,515 ($20.10) and gave the company a “buy” rating in a report on Friday, July 28th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of GBX 1,289.25 ($17.10).

ILLEGAL ACTIVITY NOTICE: This news story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at

About Smith & Nephew plc

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Receive News & Stock Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related stocks with our FREE daily email newsletter.